FCER2 and lymphadenitis: After antiestrogen therapy, the axillary LNs had fewer ERα+ cells and smaller areas of GCs and CD21+ and CD23+ FDC meshwork than axillary LNs from nonneoplastic lymphadenitis tissue (P < 0.01).